ATXS
Astria Therapeutics
ATXS
ATXS
Delisted
ATXS was delisted on the 22nd of January, 2026.
30 hedge funds and large institutions have $17.2M invested in Astria Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $41.7M → $17.2M (-$24.5M)
Holders
30
Holding in Top 10
–
Calls
$534K
Puts
–
Top Buyers
| 1 | +$2.24M | |
| 2 | +$340K | |
| 3 | +$224K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$106K |
| 5 |
Millennium Management
New York
|
+$75.8K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$2.25M | |
| 3 | -$166K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$131K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$107K |